AKRO
Akero Therapeutics Inc
NASDAQ: AKRO · HEALTHCARE · BIOTECHNOLOGY
$54.65
+0.00% today
Updated 2025-12-09
Market cap
$4.50B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.75
Dividend yield
—
52W range
$32 – $57
Volume
2.9M
Akero Therapeutics Inc (AKRO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.38M | $-4.63M | $-35.63M | $-70.80M | $-79.68M | $-92.52M | $-145.37M | $-230.11M |
| Capital expenditures | $148000.00 | $5.00M | $148000.00 | $148000.00 | $0.00 | $0.00 | $0.00 | $999000.00 |
| Depreciation | $17000.00 | $17000.00 | $-104000.00 | $17000.00 | $41000.00 | $43000.00 | $29000.00 | $18000.00 |
| Stock-based comp | — | — | — | — | — | — | — | — |
| Free cash flow | $-4.53M | $-9.63M | $-35.77M | $-70.95M | $-79.68M | $-92.52M | $-145.37M | $-231.11M |
| Investing cash flow | $-5.00M | $-5.00M | $-71.51M | $-9.76M | $42.28M | $-63.83M | $-223.62M | $-109.71M |
| Financing cash flow | $5.00M | $85.01M | $95.99M | $203.11M | $602000.00 | $255.63M | $353.32M | $445.85M |
| Dividends paid | $0.00 | $0.00 | — | — | — | — | $229.10M | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $122.54M | $-36.80M | $99.29M | — | — |